STOCK TITAN

Ginkgo Bioworks Announces Date of Third Quarter 2023 Results Presentation

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session on November 8, 2023, to review business performance for Q3 2023. The session will begin at 5:30 p.m. ET and will be available on Ginkgo's investor relations website. Questions can be submitted via Twitter or email.
Positive
  • None.
Negative
  • None.

Presentation and Q&A session scheduled for post-market on Wednesday, November 8, 2023

BOSTON, Nov. 1, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2023, on Wednesday, November 8, 2023, beginning at 5:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2023-results-presentation-301973575.html

SOURCE Ginkgo Bioworks

FAQ

When will Ginkgo Bioworks host the presentation and Q&A session?

Ginkgo Bioworks will host the presentation and Q&A session on Wednesday, November 8, 2023.

What is the purpose of the session?

The session aims to review Ginkgo Bioworks' business performance for the third quarter ended September 30, 2023.

At what time will the session begin?

The session will begin at 5:30 p.m. ET.

Where can I access the presentation details and webcast link?

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com.

Will there be a replay of the session?

Yes, a replay of the session will be made available.

How can I submit questions ahead of the presentation?

Questions can be submitted to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

409.25M
42.27M
6.15%
68.55%
13.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BOSTON